Immuno-Deficiency: Clinical Trials

2 trials for Immuno-Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow Immuno-Deficiency: new trials by email Literature Review of Immuno-Deficiency trials Research Report on Immuno-Deficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
Intensified TB treatment (initial phase), WHO standard TB treatment (initial phase) - Tuberculosis, HIV-1-infection
Phase 3CompletedANRS, Emerging Infectious Diseases13302022-04-212025-12-22
Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
SARS-CoV-2 convalescent plasma - Covid19, Immuno-Deficiency
Phase 3UnknownUniversity Hospital, Geneva1002021-04-082021-04-08

Narrower conditions

COVID-19 (1)  ·  Frailty (1)  ·  Tuberculosis (1)

Broader conditions

Infections (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)

Interventions

COVID-19 Serotherapy (1)

Sponsors

ANRS, Emerging Infectious Diseases (1)  ·  University Hospital, Geneva (1)

Countries

Cambodia (1)  ·  Cameroon (1)  ·  Guinea (1)  ·  Mozambique (1)  ·  Switzerland (1)  ·  Uganda (1)  ·  Zambia (1)

Top investigators

Enos Bernasconi, MD (1)  ·  Laurent Kaiser, MD (1)  ·  Maja Weisser, MD (1)